Treatment of iron deficiency anemia with oral iron;Tratamento da anemia ferropriva com ferro por via oral

Revista Brasileira de Hematologia e Hemoterapia

Volumn 32, Issue SUPPL. 2, 2010, Pages 114-120

  Cançado, Rodolfo D ^a   Lobo, Clarisse ^a,b   Friedrich, João Ricardo ^a,c  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b Hemocentro do Rio de Janeiro Hemorio   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Anemia, iron deficiency; Ferric compounds; Ferrous compounds; Iron deficiency

Indexed keywords

EID: 78649687198     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842010005000062     Document Type: Review

References (26)

1. Crosby WH. The rationale for treating iron deficiency anemia. Arch Intern Med 1984;144(3):471-2.
2. Baynes RD. Iron deficiency. In: Brock JH, Halliday JW, Pippard MJ, Powell LW. Iron metabolism in health disease. London, W.B. Saunders, 1994. p.189-225.
3. Cook JD. Newer aspects of the diagnosis and treatment of iron deficiency. Hematology Am Soc Hematol Educ Program, 2003; 53-61.
4. Beutler E. Disorders of iron metabolism. In: Williams Hematology. Chapter 40. Seventh Edition. McGraw-Hill, 2006;511-553.
5. Alleyne M, Horne MK, Miller JL. Individualized treatment for iron-deficiency anemia in adults. Am J Med. 2008;121(11):943-8.
6. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol. 2005;18(2):319-32.
7. Hallberg L, Ryttinger L, Solvell L. Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form Acta Med Scand Suppl. 1966; 459:3-10.
8. Toblli JE, Cao G, Olivieri L, Angerosa M. Comparative study of gastrointestinal tract and liver toxicity of ferrous sulfate, iron amino chelate and iron polymaltose complex in normal rats. Pharmacology. 2008;82(2):127-37.
9. Jacobs P, Wormald LA, Gregory MC. Absorption of iron polymaltose and ferrous sulphate in rats and humans, a comparative study. S Afr Med J. 1979;55(26):1065-72.
10. Jacobs P, Johnson G, Wood L. Oral iron therapy in human subjects. Comparative absorption between ferrous salts and iron polymaltose. J Med. 1985;15(5-6):367-77.
11. Johnson G, Jacobs P. Bioavailability and the mechanisms of intestinal absorption of iron from ferrous ascorbate and ferric polymaltose in experimental animals. Exp Hematol. 1990; 18(10):1064-9.
12. Faich F, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis. 1999;33(3):464-70.
13. Rimon E, Kagansky N, Kagansky M, Mechnick L, Mashiah T, Namir M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005;118(10): 1142-47.
14. Coutinho GG, Goloni-Bertollo EM, Pavarino-Bertelli EC. Effectiveness of two programs of intermittent ferrous supplementation for treating iron-deficiency anemia in infants: randomized clinical trial. Sao Paulo Med J. 2008;126(6):31-48.
15. Souza AI, Batista Filho M, Bresani CC, Ferreira CCL, Figueiroa JN. Adherence and side effects o f three ferrous sulfate treatment regimens on anemic pregnant women in clinical trials. Cad. Saúde Pública, 2009;25(6):1225-33.
16. Lopes MCS, Ferreira LOC, Batista FM. Uso diário e semanal de sulfato ferroso no tratamento de anemia em mulheres no período reprodutivo. Cad. Saúde Pública. 1999;15:799-808.
17. Coplin M, Schuette S, Leichtmann G, Lashner B. Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate. Clin Ther. 1991;13(5):606-12.
18. Geisser P. Safety and efficacy of iron(III)-hydroxide polymaltose complex. A review of over 25 years experience. Arzneimittelforschung. 2007;57(6A):439-52.
19. Jacobs P, Fransman D, Coghlan P. Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors. J Clin Apher. 1993;8(2):89-955.
20. Jacobs P, Wood L, Bird A. Erythrocytes: better tolerance of iron polymaltose complex compared with ferrous sulphate in the treatment of anaemia. Hematology. 2000;5(1):77-83.
21. Kavakli K, Yilmaz D, Cetinkaya B, Balkan C, Sözmen EY, Sagin FG. Safety profiles of Fe2+ and Fe3+ oral preparations in the treatment of iron defiency anemia in children. Pediatr Hematol Oncol. 2004;21(5):403-10.
22. Sas G, Nemesanszky E, Bräuer H, Scheffer K. On the therapeutic effects of trivalent and divalent iron in iron deficiency anaemia. Arzneimittelforschung. 1984;34(11):1575-9.
23. Murahovschi J, Stein ML, Careffa RC, De Andrade VL, Guerra CC, Falci M. Tratamento da ferropenia e da anemia ferropriva com o complexo de hidróxido de ferro polimaltosado por via oral, de crianças em fase de recuperação de infecções respiratórias. Ensaio duplo-cego, comparativo com sulfato ferroso. Rev Paul Ped. 1987; 5:97-104.
24. Borbolla JR, Cicero RE, Dibildox MM, Sotres RD. Complejo polimaltosado férrico vs sulfato ferroso em el tratamiento de la anemia por deficiência de hierro em lactantes. Rev Mex Pediatr, 2000;67:63-67.
25. Madero D. Eficacia y seguridad del complejo de hidroxido de hierro férrico (III) y polimaltosa (IPC) vs el hierro aminoquelado em el manejo de la anemia ferropénica em ninos. Rev AWGLA, 2007; 1:28-39.
26. Toblli JE, Brignolli R. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis. Arzneimittelforschung. 2007;57(6A):431-8.